SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : WebMD Health Corp
WBMD 66.480.0%Sep 18 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tech101 who wrote (200)12/5/2000 12:07:32 AM
From: tech101   of 326
 
Prefer to Believe This (2):

Talked to Investor relations on Friday
by: tonydunning1234 12/3/00 11:50 pm
Msg: 51673 of 51811

Talked to the head of WEBMD investor relations Ms Risa Fisher. First of let me say, she was very professional and maintained a very positive tone. Regarding share price, she said Marty has always used stock options to align Management, employee and share holder interests. I was told not to worry about employee committement that people were working very hard for the company. Next I asked about cash on hand and was told that after the sale of Porex they expect by the end of 2001 to have a little over a billion cash on hand. They are also still on track to be cash flow positive by the end of 2001. I was also told that unlike a lot of managers Marty tends to understimate rather than overestimate earnings/growth forecasts. Regarding Medunite, She calmly explained they did not think it was necessarily a bad thing. She went on further to say, competitiors in other industries have tried to align and have almost always failed due to separate agendas. In addition she told me 6 of the 7 members of Medunite are current WEBMD customers. Plus it has taken MMGR 17 years to build its corporate relationships, and HLTH now has a full suite of products and services and a fully trained sales force of over 2,000 on the street. Medunite has little staff, no clear objective, little funding, no products, no sales force. Internationally, Ms Fisher said HLTH was exploring options, and markets to include, Canada, Europe, Australia, and Japan, but not to expect these markets to have a major impact on Revenue for a few years. Regarding the limited number of press releases I was told during this strategic shift and renegotiating process they saw no need to educate the enemey. After talking to Ms Fisher, I will continue to buy at these levels. Good luck to all
messages.yahoo.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext